Validation of automated body composition analysis using diagnostic computed tomography imaging in patients with pancreatic cancer

Ali N. Gunesch, Thomas L. Sutton, Stephanie Krasnow, Christopher R. Deig, Brett C. Sheppard, Daniel L. Marks, Aaron J. Grossberg

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Sarcopenia is associated with complications and inferior oncologic outcomes in solid tumors. Axial computed tomography (CT) scans can be used to evaluate sarcopenia, however manual quantification is laborious. We sought to validate an automated method of quantifying muscle cross-sectional area (CSA) in patients with pancreatic adenocarcinoma (PDAC). Methods: Mid-L3 CT images from patients with PDAC were analyzed: CSAs of skeletal muscle (SM) were measured using manual segmentation and the software AutoMATiCA, and then compared with linear regression. Results: Five-hundred-twenty-five unique scans were analyzed. There was robust correlation between manual and automated segmentation for L3 CSA (R2 0.94, P < 0.001). Bland-Altman analysis demonstrated a consistent overestimation of muscle CSA by AutoMATiCA with a mean difference of 5.7%. A correction factor of 1.06 was validated using a unique test dataset of 36 patients with non-PDAC peripancreatic malignancies. Conclusions: Automated muscle CSA measurement with AutoMATiCA is highly efficient and yields results highly correlated with manual measurement. These findings support the potential use of high-throughput sarcopenia analysis with abdominal CT scans for both clinical and research purposes.

Original languageEnglish (US)
Pages (from-to)742-746
Number of pages5
JournalAmerican journal of surgery
Volume224
Issue number2
DOIs
StatePublished - Aug 2022

Keywords

  • AutoMATiCA
  • Body composition
  • Muscle mass
  • Pancreatic ductal adenocarcinoma
  • Sarcopenia

ASJC Scopus subject areas

  • Surgery

Fingerprint

Dive into the research topics of 'Validation of automated body composition analysis using diagnostic computed tomography imaging in patients with pancreatic cancer'. Together they form a unique fingerprint.

Cite this